Stroke-Bleed Risks Calculator
Stroke-Bleeding Risks assessment in non-valvular AF patients
The Stroke-Bleeding Risks calculator is an application designed to caclulate stroke risk (CHA2DS2-VASc score) and bleeding risk (HAS-BLED) of patients with atrial fibrillation. The use of CHA2DS2-VASc score and HAS-BLED score is recommended by the European Society of Cardiology . This application also includes examples of patient medical profiles who might benefit from the WATCHMAN™ left atrial appendage closure therapy as an alternative to oral anticoagulants.DisclaimerFor health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.Please note that the following application is exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this application contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.This application is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.Patient Profiles updateUpdate of legal information
The Stroke-Bleeding Risks calculator is an application designed to caclulate stroke risk (CHA2DS2-VASc score) and bleeding risk (HAS-BLED) of patients with atrial fibrillation. The use of CHA2DS2-VASc score and HAS-BLED score is recommended by the European Society of Cardiology . This application also includes examples of patient medical profiles who might benefit from the WATCHMAN™ left atrial appendage closure therapy as an alternative to oral anticoagulants.DisclaimerFor health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.Please note that the following application is exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this application contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.This application is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.Patient Profiles updateUpdate of legal information